IL6 and hepatocellular carcinoma: Elevated expression of IL‐6 and activation of the JAK2/STAT3 pathway are tightly correlated with the progression of malignancies, including HCC [65], colon cancer [66], bc [67], NSCLC [56], and NPC [68].